BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• China Nuokang Bio-Pharmaceutical Inc. to Participate in 29th Annual J.P. Morgan Healthcare Conference

  December 6, 2010

   · 

  1 min read
• Business

  NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) and Galderma Pharma S.A. Expand Their Agreement to Include Impetigo; Agreement Increases Potential Milestones to $62 Million Plus Double-Digit Royalties on Future Sales

  December 6, 2010

   · 

  9 min read
• Drug Development

  Cyclacel Pharmaceuticals, Inc. Reports Phase 2 Survival Data With Sapacitabine in Myelodysplastic Syndromes at 2010 American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Follow-Up Results from Study Comparing SPRYCEL(R) (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Demonstrate Improved Response Rates Consistent with 12 Month Data

  December 6, 2010

   · 

  1 min read
• Pharm Country

  Cyclacel Pharmaceuticals, Inc.'s Second Generation Cyclin-Dependent Inhibitor CYC065 Demonstrates Activity in Multiple Myeloma

  December 6, 2010

   · 

  1 min read
• Lone Star Bio

  Caris Life Sciences Presents Key Findings Related to Plasma Cell Disorders

  December 6, 2010

   · 

  1 min read
• BioCapital

  iBio, Inc. Release: Another Clinical Trial Commenced for a Product Based on iBioLaunch Technology

  December 6, 2010

   · 

  1 min read
• Biotech Beach

  Radient Pharmaceuticals Completes Annual Shareholder Meeting and Announces Voting Results; Votes for Successful Debt Recapitalization, Positions Company for Growth

  December 6, 2010

   · 

  4 min read
• Business

  Accomplished U.S. Diabetes Industry Veteran, Zoe H. Myers, Joins D. Medical as Chief Commercial Officer

  December 6, 2010

   · 

  5 min read
• BioCapital

  Sequella, Inc. Files IND and Receives FDA Go-ahead for Phase 2 Trial of SQ109 in Helicobacter pylori-associated Duodenal Ulcers

  December 6, 2010

   · 

  1 min read